JIR
AVNS

James Investment Research’s Avanos Medical AVNS Stock Holding History

James Investment Research’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-40,270
Closed -$1.86M – 781
2017
Q4 		$1.86M Buy
40,270
+470
+1% +$21.6K 0.06% 331
2017
Q3 		$1.79M Buy
+39,800
New +$1.7M 0.06% 319
2017
Q2 		– Sell
-47,606
Closed -$1.81M – 718
2017
Q1 		$1.81M Buy
+47,606
New +$1.86M 0.05% 244
2015
Q3 		– Sell
-100
Closed -$4K – 486
2015
Q2 		$4K Sell
100
-149
-60% -$6.69K ﹤0.01% 497
2015
Q1 		$12K Sell
249
-93
-27% -$4.31K ﹤0.01% 483
2014
Q4 		$16K Buy
+342
New +$13.4K ﹤0.01% 452

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CCM
Channing Capital Management Chicago, Illinois $4.34B AUM 37.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

James Investment Research's AVNS Position: Q1 2018 in Review

James Investment Research sold out of Avanos Medical (AVNS) in Q1 2018, closing a stake of 40,270 shares — an estimated $1.86M sold.

James Investment Research first reported a position in AVNS in Q4 2014 and held it in 6 quarters. The position peaked at $1.86M in Q4 2017. 338 funds tracked by Wall St. Rank hold AVNS as of Q1 2018.

  • James Investment Research reported no remaining Avanos Medical position as of Q1 2018 after selling out during the quarter.
  • James Investment Research sold 40,270 Avanos Medical shares in Q1 2018, an estimated $1.86M.
  • James Investment Research first reported a position in Avanos Medical in Q4 2014 and held it in 6 quarters.
  • James Investment Research's Avanos Medical position peaked at $1.86M in Q4 2017.
  • 338 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2018.

Based on James Investment Research's 13F filing for Q1 2018, filed 12 Apr 2018.